Essential diagnostics and devices in primary care diabetes.

Area of Science:

• Endocrinology
• Public Health
• Medical Devices

Background:

• Medications are recognized as essential in diabetes management, evidenced by inclusion in global and national Essential Medicines lists.
• The critical role of essential diagnostics and devices in diabetes care has not received adequate attention or formal recognition.
• Current healthcare frameworks inadequately address the availability and accessibility of necessary tools for diabetes management.

Purpose of the Study:

• To propose the development of a comprehensive list of essential diagnostics and devices for diabetes care.
• To highlight the gap in current essential lists regarding diagnostic and device needs in diabetes management.
• To advocate for policy changes ensuring the availability, accessibility, and affordability of essential diabetes care tools.

Main Methods:

• This communication is a call to action based on a review of current essential lists and healthcare needs.
• It synthesizes the importance of diagnostics and devices in primary, secondary, and tertiary diabetes care settings.
• The approach involves identifying the need and proposing a framework for essential item selection.

Main Results:

• Essential Medicines lists are established, but corresponding lists for essential diagnostics and devices for diabetes are lacking.
• There is a clear need for standardized lists to guide procurement and policy for diabetes management tools.
• The absence of such lists hinders equitable access to comprehensive diabetes care.

Conclusions:

• Creating lists of essential diagnostics and devices is crucial for effective diabetes care.
• Collaboration between policymakers and clinicians is vital to ensure these essential items are accessible and affordable.
• Addressing this gap will improve health outcomes for all individuals with diabetes.